Summary
The Bombay High Court criticized the Maharashtra FDA for its excessive actions against an Amazon warehouse, questioning the appropriateness of shutting down businesses for regulatory violations. The court highlighted procedural concerns during an ongoing appeal, urging a more measured approach.